KENDALL WILLIAMS: Open Payments
NPI 1720846652 · HOLLY SPRINGS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 39 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $213 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $37 |
| UROGEN PHARMA, INC. | 1 | $34 |
| Legend Biotech USA Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Lilly USA, LLC | 2 | $29 |
Products named: QULIPTA, VRAYLAR, UBRELVY, INSPIRE, CAPLYTA, Cologuard Collection Kit, ZUSDURI, CARVYKTI.
Industry payments across GA — which companies pay providers there.
